看片视频


Frank Brosius

Personal Information
Title Professor
Expertise Nephropathy
Institution University of Arizona
Newsletter? Not signed up.
Data Summary
TypeCount
Grants/SubContracts 1
Progress Reports 8
Presentations 8
Publications 36
Protocols 6
Committees 1


Progress Reports
No funding program application progress reports found.

Annual Reports
Drag a column header and drop it here to group by that column
Title YearTypeOptions
Brosius, Frank (2004)
2004Annual Report
View
Brosius, Frank (2005)
2005Annual Report
View
Brosius, Frank (2006)
2006Annual Report
View
Brosius, Frank (2007)
2007Annual Report
View
Brosius, Frank (2008)
2008Annual Report
View
Brosius, Frank (2009)
2009Annual Report
View
Brosius, Frank (2010)
2010Annual Report
View
Brosius, Frank (2011)
2011Annual Report
View


 PublicationAltmetricsSubmitted ByPubMed IDStatus

Year: 2017; Items: 2

 
Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease.
Hinder LM, Park M, Rumora AE, Hur J, Eichinger F, Pennathur S, Kretzler M, Brosius FC, Feldman EL
Journal of cellular and molecular medicine, 2017
Published
 
Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.
Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG, Werner T, Kretzler M, Brosius FC
Kidney international, 2017
Published

Year: 2016; Items: 2

 
JAK inhibition in the treatment of diabetic kidney disease.
Brosius FC, Tuttle KR, Kretzler M
Diabetologia, 2016 (59), 1624 - 7
Published
 
Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.
Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G, Groop PH, Nelson RG, Darshi M, Sharma K, Schelling JR, Sedor JR, Pop-Busui R, Weinberg JM, Soleimanpour SA, Abcouwer SF, Gardner TW, Burant CF, Feldman EL, Kretzler M, Brosius FC, Pennathur S
JCI insight, 2016 (1), e86976
Published

Year: 2014; Items: 2

 
Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.
Guzman J, Jauregui AN, Merscher-Gomez S, Maiguel D, Muresan C, Mitrofanova A, Diez-Sampedro A, Szust J, Yoo TH, Villarreal R, Pedigo C, Molano RD, Johnson K, Kahn B, Hartleben B, Huber TB, Saha J, Burke GW, Abel ED, Brosius FC, Fornoni A
Diabetes, 2014 (63), 701 - 714
Published
 
MicroRNA-21 in Glomerular Injury.
Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, Zavadil J, Nelson RG, Tuschl T, Brosius FC, Kretzler M, Bitzer M
Journal of the American Society of Nephrology : JASN, 2014
Published

Year: 2013; Items: 4

 
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.
Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC, Kretzler M
Diabetes, 2013 (62), 299 - 308
Published
 
New targets for treatment of diabetic nephropathy: what we have learned from animal models.
Brosius FC, Alpers CE
Current opinion in nephrology and hypertension, 2013 (22), 17 - 25
Published
 
How to find a prognostic biomarker for progressive diabetic nephropathy.
Brosius FC, Pennathur S
Kidney international, 2013 (83), 996 - 998
Submitted Externally
Published
 
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.
Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, Decleves AE, Andreyev A, Quach T, Ly S, Shekhtman G, Nguyen W, Chepetan A, Le TP, Wang L, Xu M, Paik KP, Fogo A, Viollet B, Murphy A, Brosius F, Naviaux RK, Sharma K
The Journal of clinical investigation, 2013 (123), 4888 - 4899
Published

Year: 2012; Items: 2

 
Do we now have a prognostic biomarker for progressive diabetic nephropathy?
Brosius FC, Saran R
Journal of the American Society of Nephrology : JASN, 2012 (23), 376 - 377
Published
 
Perspectives on systems biology applications in diabetic kidney disease.
Komorowsky CV, Brosius FC, Pennathur S, Kretzler M
Journal of cardiovascular translational research, 2012 (5), 491 - 508
Published

Year: 2011; Items: 2

 
Published
 
GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
Buller CL, Heilig CW, Brosius FC
American journal of physiology. Renal physiology, 2011 (301), F588 - F596
Published

Year: 2010; Items: 8

 
The management of diabetic neuropathy in CKD.
Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010 (55), 365 - 385
Published
 
Abnormalities in signaling pathways in diabetic nephropathy.
Brosius FC, Khoury CC, Buller CL, Chen S
Expert review of endocrinology & metabolism, 2010 (5(1)), 51 - 64
Published
 
Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H, Schin M, Saha J, Burke K, Holzman LB, Filipiak W, Saunders T, Xiang M, Heilig CW, Brosius FC
American journal of physiology. Renal physiology, 2010 (299), F91 - F98
Published
 
Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
Wang Y, Heilig K, Saunders T, Minto A, Deb DK, Chang A, Brosius F, Monteiro C, Heilig CW
American journal of physiology. Renal physiology, 2010 (299), F99 - F111
Published
 
Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.
Duan SZ, Usher MG, Foley EL, Milstone DS, Brosius FC, Mortensen RM
Diabetologia, 2010 (53), 1493 - 1505
Published
 
A new pair of SOCS for diabetic nephropathy.
Brosius FC, Banes-Berceli A
Journal of the American Society of Nephrology : JASN, 2010 (21), 723 - 724
Published
 
Published
 
Published

Year: 2009; Items: 1

 
Mouse Models of Diabetic Nephropathy: A Midstream Analysis from the Diabetic Complications Consortium
Frank C. Brosius IIIa, Charles E. Alpersb, Erwin P. Bottingerc, Matthew D. Breyerd, ThomasM. Coffmane, Susan B. Gurleye, Raymond C. Harrisf, Masao Kakokig, Matthias Kretzler, Edward H. Leiterh, Moshe Levii, Richard A. McIndoej, Kumar Sharmak, Oliver Smithiesg, Katalin Susztakl, Nobuyuki Takahashig, Takamune Takahashif
Journal of the American Society of Nephrology : JASN, 2009 (20(12)), 2503 - 2512
Published

Year: 2008; Items: 7

 
From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.
Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC
Diabetes, 2008 (57(6)), 1439 - 1445
Published
 
Rosiglitazone Treatment Reduces Diabetic Neuropathy in STZ treated DBA/2J mice
Timothy D Wiggin, Matthias Kretzler, Subramaniam Pennathur, Kelli A. Sullivan, Frank C Brosius, Eva L Feldman
Endocrinology, 2008 (149(10)), 4928 - 4937
Published
 
Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice.
Blauwkamp MN, Yu J, Schin MA, Burke KA, Berry MJ, Carlson BA, Brosius FC, Koenig RJ
BMC nephrology, 2008 (9), 7
Published
 
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy
Hongyu Zhang, Jharna Saha, MaryLee Schin, Jaeman Byun, Matthias Kretzler, Eva L. Feldman, David A. Weild, Subramaniam Pennathur, Frank C. Brosius III
American journal of physiology. Renal physiology, 2008 (295(4)), F1071 - F1081
Published
 
New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.
Brosius FC
Reviews in endocrine & metabolic disorders, 2008 (9(4)), 245 - 254
Published
 
Is the ER stressed out in diabetic kidney disease?
Brosius FC, Kaufman RJ
Journal of the American Society of Nephrology : JASN, 2008 (19), 2040 - 2042
Published
 
Enhanced Expression of JAK-STAT Pathway Members in Human Diabetic Nephropathy
Celine C. Berthier, PhD., Hongyu Zhang, M.D., MaryLee Schin, B.S., Anna Henger, PhD, Robert G. Nelson, M.D., PhD, Berne Yee, M.D., Anissa Boucherot, PhD., Christin Carter-Su, PhD., Lawrence S. Argetsinger, PhD., Maria Pia Rastaldi, M.D., Frank C. Brosius, M.D., Matthias Kretzler, M.D
Diabetes, 2008 (Epub), 469 - 477
Published

Year: 2007; Items: 1

 
Mouse models of diabetic neuropathy.
Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F, Feldman EL
Neurobiology of disease, 2007 (28(3)), 276 - 285
Published

Year: 2006; Items: 2

 
Role for GLUT1 in diabetic glomerulosclerosis.
Heilig CW, Brosius FC, Cunningham C
Expert reviews in molecular medicine, 2006 (8(4)), 1
Published
 
Reduction in Podocyte Density as a Pathologic Feature in Early Diabetic Nephropathy in Rodents: Prevention of by Lipoic Acid Treatment
Brian Siu, Jharna Saha, William E. Smoyer, Kelli A. Sullivan, Frank C. Brosius III
BMC nephrology [electronic resource], 2006 (7), 1 - 11
Published

Year: 2005; Items: 3

 
Mouse Models of Diabetic Nephropathy
MATTHEW D. BREYER, ERWIN B脰TTINGER, FRANK C. BROSIUS, III, THOMAS M. COFFMAN, RAYMOND C. HARRIS, CHARLES W. HEILIG, AND KUMAR SHARMA (FOR THE AMDCC)
Journal of the American Society of Nephrology : JASN, 2005 (16), 27 - 45
Published
 
Glucose transporters in diabetic nephropathy.
Brosius FC, Heilig CW
Pediatric nephrology (Berlin, Germany), 2005 (20(4)), 447 - 451
Published
 
Diabetic nephropathy: of mice and men.
Breyer MD, B枚ttinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K
Advances in chronic kidney disease, 2005 (12(2)), 128 - 145
Published
Drag a column header and drop it here to group by that column
Title YearTypeOptions
Brosius, Frank (10/17/2005)
2005Presentation
View
Brosius, Frank (10/19/2004)
2004Presentation
View
Brosius, Frank (2006)
2006Presentation
View
Brosius, Frank (2007)
2007Presentation
View
Brosius, Frank (2009)
2009Presentation
View
Brosius, Frank (3/23/2005)
2005Presentation
View
Brosius, Frank (6/2004)
2004Presentation
View
L) Systems Biology Workgroup
2010Presentation
View
ExperimentSpeciesStatusMeasurementsOptions
No records to display.